Daily non-political popular news in brief.

Animal study leading to new treatments for hemorrhagic shock and uncontrolled abdominal hemorrhage

Blood loss due to severe internal injuries requires rapid action to prevent mortality. In a paper to be presented at the 2007 Society for Academic Emergency Medicine Annual Meeting, James Manning, M.D., will show that Hemoglobin-Based Oxygen Carrier (HBOC)-201 resuscitation maintained survival longer than Hetastarch, and in particular, targeting a Mean Arterial Pressure (MAP) of 80 mm Hg was more favorable than a target MAP of 100 mm Hg.

Read more »

Keywords: animal, study, leading, treatments, hemorrhagic, shock, uncontrolled, abdominal, hemorrhage, treatment

« Previous | Next »

Similar news on "Animal study leading to new treatments for hemorrhagic shock and uncontrolled abdominal hemorrhage":

1. New drug shows promise for treating epileptic seizures
   04-05-2007 · EurekAlert!
   A new study appearing in the latest issue of Epilepsia shows that a new drug called Eslicarbazepine (ESL) shows promise as a treatment for epilepsy patients whose symptoms remain uncontrolled with existing medications. A once-daily dose was shown to be most effective, offering patients added convenience as current treatments can involve several doses per day.
   Similar news · Read more »
   
2. Treatment with SN reduces injury to the brain following stroke
   12-13-2007 · EurekAlert!
   Stroke is the term used to describe deteriorating brain function due to either the leaking of blood vessels (hemorrhage) or oxygen deprivation (ischemia) in the brain. A new report has revealed a beneficial effect of the protein secretoneurin in rat with ischemia-induced stroke, leading the authors of the study to suggest that SN holds promise as a small-molecule drug for the treatment of individuals who have had a stroke.
   Similar news · Read more »
   
3. Model to study age-related macular degeneration could pave way for better treatment
   10-09-2007 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine have created the first animal model of age-related macular degeneration caused by a mutation known to produce disease in people, an important first step in developing treatments.
   Similar news · Read more »
   
4. Active ingredient in common Chinese herb
   01-18-2007 · EurekAlert!
   Some 50 million Americans have hypertension, that is, blood pressure measuring above the normal range (less than 120/80 mmHg). If untreated, it can lead to heart attacks, strokes, or kidney disease. Lifestyle changes are the first-stage treatment for the disease, but if they fail, medications are prescribed. In a soon-to-be-released study using an animal model, scientists have found that tanshinone IIA, an active ingredient of danshen, reduces blood pressure.
   Similar news · Read more »
   
5. New treatment for stroke works up to a day after symptoms start
   10-01-2007 · EurekAlert!
   People treated with the drug minocycline within six to 24 hours after a stroke had significantly fewer disabilities, according to a study published in the Oct. 2, 2007, issue of Neurology, the medical journal of the American Academy of Neurology. Researchers say minocycline may be an alternative treatment for stroke because current treatments only work during the first few hours after the onset of symptoms, and many people don't get to the hospital in time to be treated.
   Similar news · Read more »
   
6. Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength
   12-17-2007 · EurekAlert!
   Noncombat-related acute and recurrent chronic pain are the leading causes of soldier attrition in modern war, with the return-to-duty rate as low as 2 percent when these soldiers are treated outside the theaters of operation. However, that rate jumps to 95 percent when troops and officers are treated and managed for pain in the field of instead of being sent elsewhere for therapy, according to a new study from a Johns Hopkins anesthesiologist.
   Similar news · Read more »
   
7. Cost-benefit analysis: Combo treatment costs more, saves money later
   11-07-2006 · EurekAlert!
   From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective, according to a new study sponsored by the Radiation Therapy Oncology Group (RTOG 91-11). Compared to higher-priced combination treatments, the least expensive, single-modality cancer treatment may cost more in the long run because of the costs associated with treating complications and recurrence of cancer.
   Similar news · Read more »
   
8. Study on toxin that tainted spinach reveals treatment possibility
   12-03-2007 · EurekAlert!
   A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it.
   Similar news · Read more »
   
9. UCSF launches study on treatment for prescription drug addiction
   04-18-2007 · EurekAlert!
   UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.
   Similar news · Read more »
   
10. Active ingredient in common Chinese herb shown to reduce hypertension
    01-18-2007 · EurekAlert!
    Some 50 million Americans have hypertension, that is, blood pressure measuring above the normal range (less than 120/80 mmHg). If untreated, it can lead to heart attacks, strokes, or kidney disease. Lifestyle changes are the first-stage treatment for the disease, but if they fail, medications are prescribed. In a soon-to-be-released study using an animal model, scientists have found that tanshinone IIA, an active ingredient of danshen, reduces blood pressure.
    Similar news · Read more »